other material
confidence high
sentiment neutral
materiality 0.60
Humacyte prices $30M registered direct offering of common stock and warrants at $5.28/unit
Humacyte, Inc.
- Offering of 5,681,820 common shares and 5,681,820 warrants at $5.28 per unit.
- Gross proceeds approximately $30M before fees and expenses.
- Warrants split: 2,840,910 expire in 6 months; 2,840,910 expire in 4.5 years; exercise price $5.28 each.
- Expected to close October 7, 2024; EF Hutton acting as placement agent with 6% fee plus expense cap.
- Offered under effective shelf registration statement on Form S-3 (File No. 333-267225).